Eli Lilly's Zepbound Coverage Restored! Breaking News | Pharma and Biotech Daily

About this episode

The episode discusses the restoration of insurance coverage for Eli Lilly's obesity medication, Zepbound, amidst significant developments in the pharmaceutical industry.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent updates offer a fascinating glimpse into an industry marked by dynamic shifts and groundbreaking advancements, each promising to reshape the future of healthcare. Let's delve into some of the most notable developments that are capturing attention across the globe. Starting with Eli Lilly's obesity medication, Zepbound, which has regained insurance covera...

People in this episode

Host: Pharma and BioTech News

Topics covered

• Eli Lilly
• Zepbound
• obesity medication
• insurance coverage
• pharmaceutical news

Keywords

• Eli Lilly
• Zepbound
• obesity
• insurance coverage
• pharmaceutical
• biotech
• healthcare

Mentioned in this episode

Organizations: Eli Lilly

Products: Zepbound

More episodes of Pharma and BioTech Daily

• Takeda's Zasocitinib Beats Sotyktu in Phase 3 Trial | Pharma and Biotech Daily · June 12, 2026 · 5 min
• Pfizer CEO Rethinks Germany Investments Amid Reform Concerns | Pharma and Biotech Daily · June 11, 2026 · 5 min
• Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! | Pharma and Biotech Daily · June 10, 2026 · 5 min
• Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success | Pharma and Biotech Daily · June 9, 2026 · 5 min
• Pfizer & Chai AI Breakthrough: $1.675B Gilead Deal | Pharma and Biotech Daily · June 8, 2026 · 5 min
• Eli Lilly & Boehringer Cut $1B+ Investments in Germany | Pharma and Biotech Daily · June 5, 2026 · 5 min